IPI Partners
SlowingFiled to raiseChicago, ILBiotechnology, Healthcare, Investment ManagementLast fund filed 2022
9 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| IPI PARTNERS III-A | April 2022 | Indefinite | $1.4B | 139 |
| IPI PARTNERS III-B | April 2022 | Indefinite | $957M | 77 |
| IPI PARTNERS III-CFiled to raise in 2022, with no closing reported yet. | 2022 | Indefinite | $0 | 0 |
| IPI Partners II-CFiled to raise in 2020, with no closing reported yet. | 2020 | Indefinite | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
10 partners are named across this firm’s filings, 9 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Thomas Lynch | Slowing | Biotech & pharma, Enterprise software, Digital health | 13 | 1 |
Classified sectors of IPI Partners’s own portfolio companies, based on 22 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Stack Infrastructure | 25 | AQ Sunshine Parent, AquaHydrex, ASPi Solutions, Bainbridge Health, Celsius Holdings, CPD to SPD, CULTIVATE MD CAPITAL FUND I, Cultivate MD Capital Fund II, cultivate(MD) Capital Accelerator Fund, Evofem Biosciences, FUSION RECRUITING LABS, Genesis Innovation Group, Genesis Software Innovations, HAPPE Spine, Magnesium Development Company, MRGB Hold, MRMMK Hold, Nanostone Water, Orexigen Therapeutics, PROFECTUS BIOSCIENCES, SHOULDER INNOVATIONS, Solecta, Synata Bio, THERMO FISHER SCIENTIFIC, XOS Technologies |
| Domain Partners | 2 | Evofem Biosciences, Orexigen Therapeutics |
| Lightstone Singapore |
| IPI Partners II-B |
| December 2019 |
| Indefinite |
| $476M |
| 61 |
| IPI Partners II-A | December 2019 | Indefinite | $1.1B | 250 |
| IPI Partners II-D | December 2019 | Indefinite | $290M | 3 |
| Brad Berkley | Quiet | None listed | 0 | 0 |
| Divesh Makan | Quiet | None listed | 0 | 0 |
| Jeffrey Felder | Quiet | None listed | 0 | 0 |
| John BerryNot on the current fund | Quiet | Enterprise software, Fintech | 2 | 0 |
| Kevin Foster | Quiet | None listed | 0 | 0 |
| Matthew A'Hearn | Quiet | Medical devices, Climate & energy, Manufacturing & industrials | 13 | 0 |
| Nitin Sathe | Quiet | None listed | 0 | 0 |
| Trey Clemens | Quiet | None listed | 0 | 0 |
| William Janes | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of IPI Partners’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| 1 |
| SHOULDER INNOVATIONS |
| Lightstone Ventures | 1 | SHOULDER INNOVATIONS |
| U.S Venture Partners | 1 | SHOULDER INNOVATIONS |
A shared board seat: a company where filings name a IPI Partners partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.